| 1 | 87090-05-9 | IRP 6 | | | | |
| 2 | 87090-18-4 | Prealbumin, from human plasma | | | | |
| 3 | 87090-27-5 | RS 49910 | | | | |
| 4 | 87090-28-6 | SULPHOSATE | C6H16NO5PS | 245.233701 | | |
| 5 | 87091-23-4 | 1,3-Dioxolo[4,5-h]isoquinoline, 6,7,8,9-tetrahydro- | C10H11NO2 | 177.2 | | |
| 6 | 87091-29-0 | Cyclohexanecarboxylic acid, 3-aMino-, Methyl ester | C8H15NO2 | 157.2102 | | |
| 7 | 87091-56-3 | 2-Oxepanone, polymer with 1,4-butanediol, 2,2-dimethyl-1,3-propanediol and 1,1'-methylenebis(4-isocyanatobenzene) | C30H42N2O8 | 558.67 | | |
| 8 | 87092-22-6 | DATP-ALPHA-S, [35S] | C10H16N5O11P3S | 512.29 | | |
| 9 | 87092-33-9 | (9Z,12E)-9,12-Tetradecadienal | C14H24O | 208.34 | | |
| 10 | 87092-34-0 | 11,14-Eicosadienoic acid, sodium salt, (Z,Z)- (9CI) | C20H37NaO2 | 332.5 | | |
| 11 | 87092-35-1 | Heneicosanoic acid, sodium salt (1:1) | C21H43NaO2 | 350.56 | | |
| 12 | 87092-47-5 | L-Glutamic acid, L-cysteinyl- | C8H14N2O5S | 250.27 | | |
| 13 | 87092-83-9 | chimeramycin B | C46H80N2O13 | 869.15 | | |
| 14 | 87093-13-8 | 1,1,1-TRIS(4-HYDROXYPHENYL)ETHANE TRIGLYCIDYL ETHER | C29H30O6 | 474.54 | | |
| 15 | 87093-92-3 | N-Formyl-L-βAsp-L-Phe-OMe | C15H18N2O6 | 322.31322 | | |
| 16 | 87094-15-3 | 2-(Ethylthio)-N,N-dimethylbenzenamine | C10H15NS | 181.3 | | |
| 17 | 87095-03-2 | 1,3-Benzodioxole,5-(2-nitropropyl)- | C10H11NO4 | 209.19864 | | |
| 18 | 87095-05-4 | Isoquinoline, 3,4-dihydro-6,7-dimethoxy-1,3-dimethyl- | C13H17NO2 | 219.28 | 77-78 °C(Solv: ligroine (8032-32-4)) | |
| 19 | 87095-74-7 | 5-Hydroxy-1,7-diphenyl-6-hepten-3-one | C19H20O2 | 280.36 | 59.5-60.5℃ | |
| 20 | 87095-75-8 | (3S,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol | C19H22O2 | 282.38 | | |
| 21 | 87095-76-9 | trans－1,7－Diphenyl－5-hydroxy-1－hepten | C19H22O | 266.37738 | | |
| 22 | 87095-77-0 | 1,7-Diphenyl-5-hydroxy-4,6-hepten-3-one | C19H18O2 | 278.35 | | |
| 23 | 87095-86-1 | 1-Propanone, 1-(4-hydroxyphenyl)-3-(2,4,6-trihydroxyphenyl)- | C15H14O5 | 274.27 | | |
| 24 | 87095-89-4 | trans-1,2-Cyclohexylenedinitrotetraacetic acid hydrate | C14H24N2O9 | 364.35 | 213-216°C(lit.) | |
| 25 | 870959-62-9 | 2-CHLORO-5-(6-METHOXY-7-(2-METHOXYETHOXY)QUINAZOLIN-4-YLAMINO)CYCLOHEXA-2,5-DIENE-1,4-DIONE | C18H16ClN3O5 | 389.79 | | |
| 26 | 870959-98-1 | 2-METHOXY-5-(6-METHOXY-7-(2-METHOXYETHOXY)QUINAZOLIN-4-YLAMINO)CYCLOHEXA-2,5-DIENE-1,4-DIONE | C19H19N3O6 | 385.37 | | |
| 27 | 87096-21-7 | 10-Undecen-1-ol, 11-bromo-, (10Z)- | C11H21BrO | 249.19 | | |
| 28 | 87096-75-1 | 2-Propenamide, N-hexyl-2-methyl- | C10H19NO | 169.26 | | |
| 29 | 87096-84-2 | Neuromedin B | C52H73N15O12S | 1132.29 | | |
| 30 | 87096-97-7 | 2-(tert-butyl)-3-methyl-2-buten-1-ol | C9H18O | 142.23862 | | |
| 31 | 870962-50-8 | 2-chloro-3,4-dimethoxy-5-nitrobenzaldehyde | C9H8ClNO5 | 245.62 | | |
| 32 | 870962-53-1 | 4-Chloro-2,3,5-triMethoxyaniline | C9H12ClNO3 | 217.64948 | | |
| 33 | 870962-74-6 | 2-ButenaMide, 4-(diMethylaMino)-N-[4-[[3,6-dioxo-4-(phenylMethoxy)-1,4-cyclohexadien-1-yl]aMino]-7-ethoxy-6-quinazolinyl]-, (2E)- | C29H29N5O5 | 527.57106 | | |
| 34 | 870964-67-3 | Evocalcet | C24H26N2O2 | 374.48 | | |
| 35 | 870964-68-4 | 2-(3-((S)-3-(((R)-1-(naphthalen-1-yl)ethyl)amino)pyrrolidin-1-yl)phenyl)acetic acid | C24H26N2O2 | 374.48 | | |
| 36 | 870964-69-5 | 2-(2-((S)-3-(((R)-1-(naphthalen-1-yl)ethyl)amino)pyrrolidin-1-yl)phenyl)acetic acid | C24H26N2O2 | 374.48 | | |
| 37 | 870966-25-9 | 870966-25-9 | C16H20N2 | 240.34 | | |
| 38 | 870966-70-4 | 1-Naphthalenecarbonitrile, 7-bromo-4-(1-pyrrolidinyl)- | C15H13BrN2 | 301.18 | | |
| 39 | 870971-19-0 | 3-Amino-6-methoxypyridine-2-carboxylic acid | C7H8N2O3 | 168.15 | | |
| 40 | 870973-92-5 | 3-[5-(chloromethyl)-1,3,4-oxadiazol-2-yl]benzonitrile | C10H6ClN3O | 219.62714 | | |
| 41 | 870974-72-4 | 3-BroMo-5-(3-chlorophenyl)-1,2,4-oxadiazole | C8H4BrClN2O | 259.49 | | |
| 42 | 870975-87-4 | Pyridine, 4-[1-(1-methylethyl)-1H-pyrazol-4-yl]- | C11H13N3 | 187.24 | | |
| 43 | 87098-48-4 | APD-III | | | | |
| 44 | 87098-49-5 | APD-I | | | | |
| 45 | 870980-07-7 | 1-[4-(3-methoxyphenyl)-6-(trifluoromethyl)pyrimidin-2-yl]piperidine-3-carboxylic acid | C18H18F3N3O3 | 381.35 | | |
| 46 | 870981-52-5 | 2-[2-BROMO-4-(HYDROXYMETHYL)-6-METHOXYPHENOXY]-N-(4-FLUOROPHENYL)-ACETAMIDE | C16H15BrFNO4 | | | |
| 47 | 870981-53-6 | 2-[5-BROMO-4-(HYDROXYMETHYL)-2-METHOXYPHENOXY]-N-(4-FLUOROPHENYL)-ACETAMIDE | C16H15BrFNO4 | 384.2 | | |
| 48 | 870983-04-3 | 1-Imidazolidineacetic acid, 4,4-dimethyl-2,5-dioxo-, 2-[(5-chloro-2-pyridinyl)amino]-2-oxoethyl ester | C14H15ClN4O5 | 354.75 | | |
| 49 | 870984-18-2 | Acetamide, 2-[(1,5-diphenyl-1H-imidazol-2-yl)thio]-N-(tetrahydro-1,1-dioxido-3-thienyl)- | C21H21N3O3S2 | 427.54 | | |
| 50 | 870984-20-6 | Benzamide, N-cyclopentyl-2-[[2-[[1-(3-fluorophenyl)-1H-tetrazol-5-yl]thio]acetyl]amino]- | C21H21FN6O2S | 440.49 | | |
| 51 | 870984-34-2 | WAY-326578 | C14H12N2O2S3 | 336.44 | | |
| 52 | 870987-63-6 | (4,4'-Di-t-butyl-2,2'-bipyridine)bis[3,5-difluoro-2-[5-trifluoromethyl-2-pyridinyl-kN)phenyl-kC]iridium(III) hexafluorophosphate | F6P- | 144.9641802 | >300 °C | |
| 53 | 870987-64-7 | Di-μ-chlorotetrakis[3,5-difluoro-2-[5-trifluoromethyl-2-pyridinyl-kN)phenyl-kC]diiridium(III) | C48H20Cl2F20Ir2N4 | 1488.02 | | |
| 54 | 870987-68-1 | 2-Propynyl [3-(Triethoxysilyl)propyl]carbamate | C13H25NO5Si | 303.43 | | |
| 55 | 870987-89-6 | 1-(4-chloro-1,2,5-thiadiazol-3-yl)-4-methylpiperazine(SALTDATA: HCl) | C7H11ClN4S | 218.71 | | |
| 56 | 870987-93-2 | 1-Benzyl-4-(4-chloro-[1,2,5]thiadiazol-3-yl)-piperazine | C13H15ClN4S | 294.8 | | |
| 57 | 87099-50-1 | Isofistularin-3 | C31H30Br6N4O11 | 1114.01 | | |
| 58 | 87099-54-5 | [6aS,(+)]-12,12aα,13,14-Tetrahydro-13-methyl-6H-6aβ,14β-epoxy-1,3-dioxolo[4,5-i][1,3]dioxolo[5,6]indeno[2,1-c][2]benzazepine | C20H17NO5 | 351.35 | | |
| 59 | 87099-71-6 | 3-P-Coumaroylquinic acid | C16H18O8 | 338.31 | | |
| 60 | 87099-72-7 | Cyclohexanecarboxylic acid, 1,3,4-trihydroxy-5-[[(2E)-3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl]oxy]-, (1R,3R,4S,5R)- | C17H20O9 | 368.34 | | |
| 61 | 87099-75-0 | Cyclohexanecarboxylic acid, 1,3,4-trihydroxy-5-[[(2Z)-3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl]oxy]-, (1R,3R,4S,5R)- | C17H20O9 | 368.34 | | |
| 62 | 87099-78-3 | Cyclo[L-α-aspartyl-D-leucyl-L-leucyl-(3R)-3-hydroxytetradecanoyl-L-α-glutamyl-L-leucyl-D-leucyl-L-valyl] | C52H91N7O13 | 1022.34 | | |
| 63 | 87099-85-2 | N-(1H-Purin-6-yl)-4-[[[(14-methyl-1-oxopentadecyl)amino]acetyl]amino]-4-deoxy-β-L-glycero-L-manno-heptopyranosylamine | C30H51N7O7 | 621.76864 | | |
| 64 | 87099-89-6 | Benz[a]anthracene-1r,2t,3c,4t-tetrahydro-1,2,3,4-tetrol | C18H16O4 | 296.31724 | | |
| 65 | 870990-64-0 | 9,16-Heptadecadiene-4,6-diyne-2,3,8-triol, (2R,3S,8S,9Z)- | C17H24O3 | 276.37 | | |
| 66 | 870991-68-7 | (1S,2S)-1,2-Bis(2-hydroxyphenyl)ethylenediamine | C14H16N2O2 | 244.29 | | |
| 67 | 870991-70-1 | (1R,2R)-1,2-BIS(2-HYDROXYPHENYL)ETHYLENEDIAMINE | C14H16N2O2 | 244.28904 | 157-163 °C | |
| 68 | 870992-10-2 | 4,4-Difluoro-8(4'-hydroxyphenyl)-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene, 98% | C19H19BF2N2O | 340.17 | | |
| 69 | 870992-11-3 | CHEMBRDG-BB 4018382 | C5H10N4 | 126.16 | | |
| 70 | 870992-75-9 | (2S,3S)-3-fluoropyrrolidine-2-carboxylic acid | C5H8FNO2 | 133.12 | | |
| 71 | 870994-56-2 | 1,4,7,10-Tetraazacyclododecane-1-butanoic acid, 4,7,10-tris(3-carboxy-1-oxopropyl)-γ-oxo- | C24H36N4O12 | 572.57 | | |
| 72 | 870995-64-5 | 5-Methoxystrictamine | C21H24N2O3 | 352.44 | | |
| 73 | 870996-60-4 | 4(3H)-Quinazolinone, 8-methoxy-2-[2-methoxy-4-[3-[(3S)-3-methyl-1-piperidinyl]propoxy]phenyl]-3-methyl- | C26H33N3O4 | | | |
| 74 | 870996-72-8 | 4(1H)-Quinazolinone, 2-[4-[(1-cyclobutyl-4-piperidinyl)oxy]phenyl]-8-methoxy- (9CI) | C24H27N3O3 | | | |
| 75 | 870996-75-1 | 4(3H)-Quinazolinone, 2-[6-[(1-cyclobutyl-4-piperidinyl)oxy]-3-pyridinyl]-8-methoxy-3-methyl- | C24H28N4O3 | | | |
| 76 | 870996-94-4 | 4(3H)-Quinazolinone, 2-[2-[(1-cyclobutyl-4-piperidinyl)oxy]-5-pyrimidinyl]-8-methoxy-3-methyl- | C23H27N5O3 | 421.49 | | |
| 77 | 870997-30-1 | 4(3H)-Quinazolinone, 8-methoxy-3-methyl-2-[4-[3-(1-pyrrolidinyl)propoxy]phenyl]- | C23H27N3O3 | | | |
| 78 | 870997-42-5 | 4(3H)-Quinazolinone, 2-[4-[(1-cyclobutyl-4-piperidinyl)oxy]phenyl]-8-methoxy-3-methyl- | C25H29N3O3 | 419.52 | | |
| 79 | 870997-45-8 | 4(3H)-Quinazolinone, 2-[4-[(1-cyclopropyl-4-piperidinyl)oxy]phenyl]-8-methoxy-3-methyl- | C24H27N3O3 | 405.49 | | |
| 80 | 870997-57-2 | 2-amino-N,3-dimethylbenzamide | C9H12N2O | 164.2 | 115-117 °C | |
| 81 | 870997-76-5 | 3-AMino-4-Methoxypicolinic acid | C7H8N2O3 | 168.15002 | | |
| 82 | 870997-81-2 | 3-Amino-2-methoxyisonicotinic acid | C7H8N2O3 | 168.15 | | |
| 83 | 870997-82-3 | 2-Methoxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)isonicotinic acid | C12H16N2O5 | 268.27 | | |
| 84 | 870997-85-6 | 3-amino-5-bromopyridine-2-carboxylic acid | C6H5BrN2O2 | 217.02 | >170°C (dec.) | |
| 85 | 870997-87-8 | N-Methyl-2-aminopyridine-3-carboxamide | C7H9N3O | 151.17 | | |
| 86 | 870997-99-2 | Adenosine 5′-(tetrahydrogen triphosphate), 2′-O-[(2-nitrophenyl)methyl]- | | 642.3 | | |
| 87 | 870998-13-3 | CXCR3 Antagonist 6c | C30H32Cl3N5O3 | 616.97 | | |
| 88 | 870998-78-0 | [PERFLUORO(POLYPROPYLENEOXY)]METHOXYPROPYLTRIMETHOXYSILANE,20%influorinatedhydrocarbon | | | | |